Signaling pathways
-
BA1859 PeretinoinSummary: Peretinoin is an orally administered non-cyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors, such as and ... - BA1861 OglufanideSummary: Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus that inhibits vascular endothelial growth factor.
- BA1863 ITX5061Summary: The ITX5061 is a Type II inhibitor.
- BA1864 R-1479Summary: R-1479 (4'-Azidocytidine) is a nucleoside analog that is a specific RNA-dependent RNA polymerase inhibitor.
- BA1871 PF-4878691Summary: PF-4878691 (3M-852A) is an orally active agonist.
- BA1873 MiravirsenSummary: Miravirsen (SPC-3649) is a potent inhibitor of miR-122 biogenesis.
- BA1874 FilibuvirSummary: Filibuvir is an orally effective, selective non-nucleoside inhibitor of the non-structural 5B protein RNA-dependent RNA polymerase (RdRp).
- BA1876 IDX184Summary: IDX184 is a potent, orally active replication inhibitor.
- BA1877 Nucleoside-Analog-2Summary: Nucleoside-Analog-2 is a 4'-azacytidine analog that targets hepatitis C virus replication.
- BA1880 SamatasvirSummary: Samatasvir (IDX71) is a potent, orally active replication inhibitor.